Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Virology Journal|June 2, 2023
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohortChung-Feng Huang, Tyng-Yuan Jang, Ping-Hsun Wu, et al.Scientific Reports|April 15, 2021
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analoguesTyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analoguesTyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.Plos One|November 20, 2020
The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis CJia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, et al.Journal of Viral Hepatitis|February 3, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like GroupYu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee, et al.Clinical and Molecular Hepatology|December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysisPo-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.American Journal of Cancer Research|January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinomaPo-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.Cancer Medicine|November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levelsPo-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.Pageof 10